It's right in the Q1 early released figures.
Why add more rooms in Vegas if they can't fill the ones they have?
How about those who golf? Probably lose those when the golf course is gone.
The pre-release Q1 numberss showed cash was well below the amount needed to make payment on time..
Company already said they would have report out before end of April. So why raise interest expenses going forward just to get an extra month the release report? Ackman already failing on BOD for allowing interest rates to be raised on the debt imo.
Simple, they lack the cash to pay their debt. They need time to scrape up some cash!
Wynn actually had MORE tables and slots in Macau Y-O-Y and numbers still disappointed. Not what I expected after Steve's Q4 report. I thought Macau was looking up after first 6 or 7 weeks of 2016? Isn't that what we were hearing?
And Vegas room occupancy stinks. Are they laying off maids or lowering room rates to get empty rooms filled? Are the tighter games hurting visitation?
And how much water will evaporate each day at this new lake resort in the nasty Vegas heat? Where will they get water to replace it every day?
I say we head back to $70 within the next couple months.
Check his med records. See if he was really sick or hiding from shareholders for 2 months.
But they obviously won't
Some are probably confused by the dilution and the effect it had on EPS. The negative EPS would be bigger had the share count remained lower.
Should show they are nearly out of cash and Softbank will be forced to act. The 15%'ers can't ride for free!
It's been "dipping" for nearly 10 years!
Softbank will buy the rest of the shares DIRT CHEAP!
how does he short stocks without margin?
See my calls on PRAN and VRX?
At $12, I said PRAN would trade below $1 and Reverse-Split. Done!
At near $70, I said VRX would see $40. Done! Down 50% today alone!
I very much have a clue. I KNOW you are a paid Pumper and have been for over 6 years on Sprint!!!
Sentiment: Strong Sell
There is marketing and it's too expensive. How much is being spent on TV commercials? Problem is, does Obamacare and other plans ALLOW doctors to prescribe $1000 toe fungus and other "jacked up" drugs?
Will their drugs be relevant long enough to pay off the debt, or will patents run out and generic drugs take over?
That's why I say the revenues are "endangered".
How do you know what you're buying?
Are their top drugs falling or climbing in sales?
They didn't offer much in the releases imo.
How does it get paid down?
With MAYBE just $11B of "endangered" revenue, the company is worth less than $30B. If it's worth less than the debt, then the shares are worth 0.